INTRODUCTION
Smooth-muscle contraction is activated by Ca# + \calmodulin (CaM)-dependent myosin-light-chain kinase (MLCK)-catalysed phosphorylation of the 20 kDa light chains (LC #! ) of myosin [1, 2] . Myosin-light-chain phosphatase (MP) also has a key role in the regulation of smooth-muscle contractility because the ratio of phosphorylated to unphosphorylated myosin, the major determinant of force development, depends on the relative activities of MLCK and MP [1, 2] . Consequently, the regulation of MP has been the focus of much attention [3] . Inhibition of MP can be effected by signalling pathways acting via arachidonic acid [4, 5] , protein kinase C and the protein kinase C (PKC)-potentiated inhibitory protein of type 1 phosphatase (CPI-17) [6] [7] [8] [9] , or RhoA and Rho-associated kinase [10] [11] [12] [13] [14] [15] , leading to Ca# + sensitization. In contrast, NO and NO-generating agents, acting via the activation of soluble guanylate cyclase, the production of cGMP and the activation of cGMP-dependent protein kinase, trigger the activation of MP and Ca# + desensitization [16] [17] [18] .
q has been widely used as a pharmacological tool to inhibit Ca# + -induced Ca# + release via blockade of the ryanodine receptor Ca# + release channel in the sarcoplasmic reticulum (SR) of several types of muscle, including smooth muscle [19] [20] [21] . However, several additional effects of RuR have been reported. RuR inhibits the plasma membrane Ca# + pump [22] , Ca# + uptake into mitochondria [23] , voltage-dependent L-type Ca# + channels and large-conductance Ca# + -dependent K + channels [24] . It also Abbreviations used : ATP [S] , adenosine 5h-[γ-thio]triphosphate ; CaM, calmodulin ; CPI-17, protein-kinase-C-potentiated inhibitory protein of type 1 phosphatase ; LC 20 , 20 kDa light chains of smooth-muscle myosin ; ML-9, 1-(5-chloronaphthalene-1-sulphonyl)-1H-hexahydro-1,4-diazepine ; MLCK, myosin-light-chain kinase ; MOPSO, 2-hydroxy-3-morpholinopropanesulphonic acid ; MP, myosin-light-chain phosphatase ; MYPT, myosin-targeting subunit of MP ; PKC, protein kinase C ; PP1cδ, catalytic subunit of the δ isoform of type 1 protein phosphatase ; R2G, relaxing solution containing 2 mM EGTA ; RuR, Ruthenium Red ; SR, sarcoplasmic reticulum. 1 To whom correspondence should be addressed (e-mail : yimaizum!phar.nagoya-cu.ac.jp).
6n3 but had little effect on contraction induced by microcystin at this [Ca# + ]. Ca# + -independent contraction was induced by RuR (EC &! 843 µM) and by microcystin (EC &! 59 nM) but the maximal force induced by RuR was smaller than that induced by microcystin. The addition of 300 µM RuR enhanced the contraction induced by 30 nM microcystin but markedly decreased that induced by 1 µM microcystin. Such a dual action of RuR on microcystin-induced effects was not observed in experiments using purified MP. We conclude that the RuR-induced Ca# + sensitization of smooth-muscle contraction is due to the direct inhibition of MP by RuR.
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decreases the Ca# + sensitivity of Ca# + uptake into cardiac SR [25] and interacts with Ca# + -binding proteins such as calsequestrin, the SR Ca# + -ATPase and EF-hand-containing Ca# + -binding proteins, including CaM and troponin C [26] . RuR inhibits Ca# + binding to CaM and has thereby been proposed to suppress smooth-muscle contractility via the inhibition of MLCK [27] .
We were therefore surprised to find that, in spite of the demonstrated inhibition of MLCK by RuR via blockade of Ca# + binding to CaM [27] , the application of RuR to permeabilized strips prepared from several types of smooth muscle markedly increased the Ca# + sensitivity of the contractile system, concomitant with an increase in LC #! phosphorylation [28] . The features of RuR-induced Ca# + sensitization in permeabilized smooth-muscle strips, e.g. a decrease in the rate of relaxation in the presence of RuR upon changing [Ca# + ] from pCa 5n0 to more than 8n0, suggested the inhibition of MP as a possible mechanism, but no direct evidence was obtained.
The present study was therefore undertaken to elucidate the mechanism of RuR-induced Ca# + sensitization of the smoothmuscle contractile system, with the use of permeabilized muscle preparations and purified MP.
MATERIALS AND METHODS

Tension measurement
Male Hartley guinea-pigs, weighing 300-350 g, were stunned by a blow on the head and immediately exsanguinated. The terminal portion of the ileum was removed and longitudinal muscle strips [15, 35] . The subsequent contraction at pCa 6n3 was larger than the first one, presumably due to the inhibition of MP by thiophosphorylation of MYPT. Under these conditions, the Ca 2 + sensitizing effect of RuR was not observed, whereas further contraction was induced by pCa 4n5 solution (panel b). (C) Cumulative data obtained from experiments similar to those shown in (A) and (B). The amplitude of contraction at pCa 6n3 just before the application of 300 µM RuR was taken as 100 % in each preparation. Open and filled bars indicate the amplitude of contraction before and after the application of RuR respectively. Left two columns : the application of RuR markedly enhanced the contraction (* P 0n05 compared with 100 %, n l 5). Right two columns : after treatment with ATP[S] and ML-9, contraction at pCa 6n3 was unaffected by 300 µM RuR (P 0n05 compared with 100 %, n l 7).
(250 µm in width, 100 µm in depth and 1n5-2 mm in length) were dissected. For tension measurements the muscles were maintained horizontally between two hooks and immersed in a pool of solution (300 µl) that was rounded by surface tension on a rotation plate 40 mm in diameter. Tension measurements were performed as described previously [29] . To prevent a change in surface tension and ionic strength of the solution by evaporation, the muscle was transferred from pool to pool at intervals of approx. 10 min. The transfer occasionally resulted in a spike-like artifact in the tension recording. The electrical signals of the tension recording were filtered with a low-pass filter at 10 Hz (k3 dB). Strips were allowed to equilibrate at a predetermined optimal resting tension of 100-200 mg for approx. 60 min before the start of each experiment. The preparation was then repeatedly exposed to 142n9 mM K + solution at intervals of approx. 30 min until the contraction was reproducible. Experiments were performed at room temperature (21-24 mC).
Smooth-muscle permeabilization
After measuring steady contractions induced by 142n9 mM K + solution, strips were incubated in relaxing solution containing 2 mM EGTA (R2G) for 20 min. Permeabilization of the smoothmuscle preparations was achieved by incubation with 60 µM β-escin in a solution of pCa 6n3 at room temperature. After permeabilization, the solution was changed to R2G. The pCa of R2G was more than 8n0, assuming Ca# + contamination of the solution to be less than 50 µM. When the Ca# + sensitivity of the contractile response was studied in detail, intracellular Ca# + storage sites were depleted by treatment of permeabilized muscle strips for 20 min with 10 µM A23187 in R2G.
Assay of purified smooth-muscle MP
The effect of RuR on the activity of purified smooth-muscle MP was determined with phosphorylated chicken gizzard myosin as substrate. Myosin, MLCK, MP and CaM were prepared as described previously [30] [31] [32] [33] . The assay was performed at 25 mC in 200 µl of reaction mixture containing 20 mM 2-hydroxy-3-morpholinopropanesulphonic acid (MOPSO)\KOH (pH 7n0 at 25 mC), an appropriate amount of KCl to adjust the ionic strength to 0n15 M, 1 mM EDTA, 0n5 mM dithiothreitol, 0n2 µM phosphorylated myosin and 0n16 nM MP, with various concentrations of RuR and\or microcystin-LR (a potent myosin phosphatase inhibitor). Purified MP was preincubated with drugs in the reaction mixture for 2 min (see Figure 3 ) or 20 min (see Figure 7 ) at 25 mC. Reactions were started by the addition of phosphorylated myosin and stopped after 1 min by the addition of 200 µl of ice-cold 10 % (w\v) trichloroacetic acid. The resulting mixture was centrifuged at 15 000 rev.\min (16 000 g) for 5 min at 4 mC (Hitachi Himic CF15D) and the precipitate was washed twice with acetone to remove trichloroacetic acid. The washed precipitate was dried, dissolved in 12n5 µl of lysis buffer [9n5 M urea\2 % (w\v) Nonidet P40\2n8 % (w\v) Pharmalyte (pH 4n5-5n4)\5 % (v\v) 2-mercaptoethanol] and centrifuged at 15 000 rev.\min (16 000 g) for 2 min at room temperature (Eppendorf centrifuge 3200) to remove insoluble material. The supernatant was subjected to two-dimensional isoelectric focusing\SDS\PAGE as described previously [32] . After staining of the gel with Coomassie Brilliant Blue, the densities of the spots of phosphorylated and unphosphorylated LC #! were measured with a MasterScan Interpretive densitometer (Scanalytics, Billerica, MA, U.S.A.).
Solutions
The composition of the standard Hepes-buffered solution was 137n0 mM NaCl\5n9 mM KCl\1n2 mM CaCl # \14n0 mM glucose\ 10n0 mM Hepes. The pH of all Hepes-buffered solutions was adjusted to 7n4 with NaOH. A high [K + ] solution was prepared by replacing NaCl with equimolar KCl. Ca# + -free solutions was prepared by replacing Ca# + with 2 mM EGTA. The apparent stability constant of CaEGTA at 23 mC and pH 7n0 was 106n35 M −" and the method for the calculation of pCa (computer program SP 6802) was originally described by Horiuchi [34] . The ionic strength of the solution was maintained at 0n2 M by adjusting the concentration of potassium methanesulphonate. The pH was adjusted to 7n0 with KOH at 23 mC. Ruthenium Red inhibits smooth-muscle myosin phosphatase
Statistics
Results are expressed as meanspS.E.M. Statistical significance was examined by using a paired Student t test. The symbols * and ** indicate P 0n05 and P 0n01 respectively against the control.
Materials
The following compounds were obtained from the sources shown in parentheses : RuR, dithiothreitol, trichloroacetic acid, urea, 2-mercaptoethanol and Coomassie Brilliant Blue (Wako Pure Chemical Industries), microcystin-LR (Research Biochemicals International), 1-(5-chloronaphthalene-1-sulphonyl)-1H-hexahydro-1,4-diazepine (ML-9), adenosine 5h-[γ-thio]triphosphate (ATP[S]), β-escin and Nonidet P40 (Sigma-Aldrich Co.), EGTA, EDTA and MOPSO (Dojindo), A23187 (Molecular Probes) and Pharmalyte (Amersham Pharmacia Biotech).
RESULTS
Effects of RuR and ATPγ[S] on permeabilized smooth muscle
Figure 1(A) shows the typical Ca# + sensitization induced by 300 µM RuR in a permeabilized strip of the longitudinal layer of guinea-pig ileum in pCa 6n3 solution, a [Ca# + ] sufficient to activate a submaximal contraction. This preparation was treated with β-escin to permeabilize the plasma membrane and with the Ca# + ionophore A23187 to destroy SR function. The tonic contraction in pCa 6n3 solution was enhanced by the addition of 300 µM RuR, as described previously [28] . The Ca# + sensitizing effect of RuR was reversed on washout. Cumulative data show an average approx. 4-fold increase in force in response to RuR ( Figure 1C) .
Treatment of permeabilized smooth-muscle strips with ATP[S] resulted in the thiophosphorylation of proteins, including the myosin-targeting subunit of MP (MYPT), resulting in decreased MP activity and increased sensitivity of the contractile apparatus to Ca# + [35, 36] . In Figure 1 (B) a permeabilized muscle strip was treated with 1 mM ATP [S] in the presence of 300 µM ML-9, which inhibits MLCK and therefore prevents LC #! thiophosphorylation. Under these conditions, MYPT but not LC #! was expected to be thiophosphorylated, as shown by The maximal contraction at pCa 5n0 was taken as 100 % in each preparation. Open and solid columns indicate the relative amplitudes of contraction at pCa 6n3 in preparations without or with RuR treatment between the first and second trials of pCa 6n3 solution, respectively (n l 5). P 0n01 compared with the first pCa 6n3 contraction ; * P 0n05 compared with the second pCa 6n3 contraction (after incubation with RuR).
Buus et al. [36] . This thiophosphorylation inhibits MP activity. Accordingly, the contractile response to the second trial of pCa 6n3 after the ATP[S] treatment was significantly larger than that to the first trial before thiophosphorylation ( Figure 1B ). Without ATP[S] treatment the amplitude of the contraction in the second trial at pCa 6n3 was comparable to that of the first trial (108n4p13n8 % ; n l 5, P 0n05). After treatment with ATP[S], the contraction in pCa 6n3 solution was not enhanced by 300 µM RuR (Figures 1Bb and 1C , 130n2p17n5 % of that just before the application of RuR ; n l 5, P 0n05). 
RuR prevents the inhibition of MP induced by thiophosphorylation
Effect of RuR on purified smooth-muscle MP activity
To address the possibility of direct inhibition of MP by RuR, the activity of purified smooth-muscle MP was assayed in the absence and presence of RuR. The dephosphorylation of phosphorylated myosin by purified MP was quantified by two-dimensional gel electrophoresis. The activity of purified MP was 4n2 µmol\min per mg. Figure 3(A) shows the separation of unphosphorylated, monophosphorylated and diphosphorylated LC #! after incubation with MP in the presence of 6n8 (Figure 3Aa ) or 68 µM RuR (Figure 3Ab ), corresponding to MP activities of 3n2 and
Figure 3 Inhibitory effect of RuR on purified smooth-muscle MP activity
(A) Purified chicken gizzard MP was preincubated with 6n8 µM (a) or 68 µM RuR (b) at 25 mC for 2 min. Reactions were started by the addition of phosphorylated myosin, terminated after 1 min of incubation by the addition of ice-cold 10 % (w/v) trichloroacetic acid and subjected to two-dimensional isoelectric focusing (IEF)/SDS/PAGE to separate unphosphorylated and phosphorylated LC 20 . Myosin, myosin-P and myosin-2P indicate unphosphorylated, monophosphorylated and diphosphorylated LC 20 respectively. (B) Concentration-dependent inhibition of purified MP by RuR. Specific activity is expressed as µmol of dephosphorylated myosin/min per mg of MP. A value of 100 % corresponds to 4n2 µmol/min per mg. An IC 50 of approx. 23 µM was determined.
0n9 µmol\min per mg respectively. The specific activity of MP was inhibited by RuR in a concentration-dependent manner, as shown in Figure 3(B) . The data were well fitted by a Hill plot with a coefficient of 1n1, suggesting 1 : 1 stoichiometry of RuR binding to MP. The IC &! was calculated to be approx. 23 µM.
Effect of CaM on microcystin-or RuR-induced Ca 2 + sensitization
It has been reported that RuR inhibits Ca# + binding to CaM [27] . It was therefore unexpected to find that RuR induced Ca# + sensitization in permeabilized smooth muscle [28] . We tested the hypothesis that the inhibition of Ca# + binding to CaM by RuR might partly inhibit Ca# + sensitization triggered by RuRmediated inhibition of MP. The application of 10 nM microcystin, a potent type 1 and 2A protein phosphatase inhibitor [37] , or 100 µM RuR enhanced the tonic contraction in pCa 6n3 solution to almost the same extent (30n4p3n9 % and 38n7p7n0 % of the control contraction at pCa 5n0 respectively ; n l 7, P 0n05 ; Figure 4A ). The addition of 1 µM CaM enhanced these contractions but the enhancement in the presence of RuR was significantly larger than that in the presence of microcystin : to 71n2p7n4 % compared with 44n1p4n7 % of the control contraction at pCa 5n0 respectively (n l 7, P 0n05 ; Figure 4B ). It can therefore be concluded that the effect of exogenous CaM was significantly greater in RuR-treated than in microcystin-treated smooth-muscle strips.
Ca 2 + -independent contraction induced by microcystin and RuR
It has been reported that the application of microcystin induces a tonic contraction of permeabilized smooth muscle in Ca# + -free solution [38, 39] . The maximum contraction at pCa 5n0 was taken as 100 % in each preparation. EC 50 values of 59n2p9n4 nM and 843n1p42n1 µM were determined for microcystin and RuR respectively. The maximum contraction induced by RuR was significantly smaller than that due to microcystin (* P 0n05).
Figure 6 Dual effect of RuR on microcystin-induced contraction
(A) The application of either 30 nM microcystin or 300 µM RuR induced only a small or no contraction in R2G solution. The addition of 300 µM RuR to 30 nM microcystin resulted in a substantial contraction (a). Cumulative data are shown in (b). The maximum contraction at pCa 5n0 was taken as 100 % in each preparation. The relative amplitude of contraction in the presence of both 300 µM RuR and 30 nM microcystin was significantly larger than those induced by each compound alone (n l 5, ** P 0n01). (B) The tonic contraction induced by 1 µM microcystin was markedly suppressed by the addition of 300 µM RuR (a). Cumulative data are shown in (b). The relative amplitude of contraction in the presence of both 1 µM microcystin and 300 µM RuR was significantly smaller than that induced by microcystin alone (n l 5, ** P 0n01).
Figure 7 Effect of microcystin on the activity of purified smooth-muscle MP in the absence and presence of RuR
The concentration-dependent inhibition of MP activity by microcystin in the absence (#) or presence of RuR (300 µM) ($) was determined as shown in Figure 3 , except that the reaction mixture without phosphorylated myosin was preincubated for 20 min at 25 mC before reactions were started. The IC 50 for microcystin was approx 0n2 nM. Circles on the ordinate indicate the activities in the absence of microcystin and in the absence and the presence of RuR. MP activity was abolished in the presence of 300 µM RuR and was unaffected by the addition of microcystin. The results are means of duplicate measurements.
the concentration-response relationships of microcystin-and RuR-induced contractions. The amplitude of contraction in pCa 5n0 solution was taken as 100 % in each preparation. The EC &! of microcystin was approx. 10 −% that of RuR (59n2p9n4 nM compared with 843n1p42n1 µM respectively ; n l 5, P 0n01). The maximum contraction induced by RuR was significantly smaller than that induced by microcystin (48n2p8n2 % compared with 70n7p5n1 % respectively of the initial pCa 5n0-induced contraction ; n l 5, P 0n05 ; Figure 5B ).
Dual action of RuR on microcystin-induced contraction
Ca# + -independent contractions shown in Figure 5 were hardly observed after the application of a low concentration of microcystin (less than 10 nM) or RuR (less than 300 µM). A single application of 30 nM microcystin or 300 µM RuR induced only a very small tonic contraction in Ca# + -free solution (R2G, pCa 8) : 4n2p3n1 % and 4n7p2n8 % of the control contraction at pCa 5n0 (n l 5 ; Figure 6A ). When 300 µM RuR was added in the presence of 30 nM microcystin, however, substantial contraction was induced (25n1p2n9 % of the control contraction at pCa 5n0; n l 5, P 0n01 compared with microcystin or RuR alone ; Figure 6A ). We therefore conclude that microcystin and RuR act in a synergistic fashion with regard to MP inhibition.
In contrast, the same concentration of RuR (300 µM) markedly inhibited the contraction induced by 1 µM microcystin (from 86n0p8n8 % to 22n7p3n0 % of the control contraction at pCa 5n0; n l 5, P 0n01 ; Figure 6B ).
Effects of RuR on purified smooth-muscle MP activity in the presence of microcystin
The possibility that 300 µM RuR might antagonize the inhibitory effect on MP of high concentrations of microcystin was examined ( Figure 7 ). The activity of purified smooth-muscle MP was decreased by microcystin in a concentration-dependent manner with an IC &! of approx. 0n2 nM, as seen previously. MP was completely inhibited by 300 µM RuR (see Figure 3 ) and did not decrease the inhibition due to 0n01-1 nM microcystin. Inhibition of the phosphatase by microcystin was therefore not antagonized by a high concentration of RuR.
DISCUSSION
The present study demonstrates for the first time that RuR directly inhibits the activity of MP to enhance LC #! phosphorylation and increase the Ca# + sensitivity of contraction in permeabilized smooth muscle. We previously showed that RuR induces Ca# + sensitization [28] . In the present study we elucidated the mechanism whereby RuR enhances the Ca# + sensitivity of contraction, which involves direct inhibition of MP.
The IC &! of RuR for the inhibition of purified MP was 23 µM under the present experimental conditions, indicating that MP can be inhibited by RuR at slightly lower concentrations than those required for Ca# + sensitization of permeabilized smooth muscle : EC &! values for the potentiation at pCa 6n0 in permeabilized muscle strips prepared from urinary bladder and ileal longitudinal layer were approx. 60 and 110 µM respectively, and that at pCa 6n3 in mesenteric artery was approx. 50 µM [28] . This difference between IC &! and EC &! values is due, at least in part, to the inhibitory effect of RuR on Ca# + binding to CaM (K i 9 µM [27] ). Exogenously added CaM markedly enhanced the potentiating effect of RuR on the contraction at pCa 6n3, whereas the enhancement by CaM of microcystin-induced potentiation was significantly smaller. Ca# + sensitization induced by RuR is therefore partly attenuated by the inhibition of Ca# + binding to CaM by RuR.
The results obtained with ATP[S] and ML-9 support the hypothesis that MP inhibition by RuR is the major mechanism underlying RuR-induced sensitization of permeabilized muscle strips to Ca# + . It was clearly shown that the enhancement of contraction at pCa 6n3 by RuR was not observed when the permeabilized muscle strip had already been sensitized by MP thiophosphorylation. Of importance is the observation that the thiophosphorylation of MP was inhibited by the simultaneous presence of RuR and ATP [S] . This suggests that the binding of RuR to MP masks the site of (thio)phosphorylation. Alternatively, RuR might inhibit MP kinase in addition to MP itself. It has been reported that MP activity is down-regulated by phosphorylation via signal transduction pathways including the PKC-catalysed phosphorylation of CPI-17, a 17 kDa protein substrate of PKC that becomes a potent inhibitor of MP after phosphorylation [7] , and the Rho-associated kinasecatalysed phosphorylation of MYPT [11] . In our previous study, RuR-induced Ca# + sensitization was not inhibited by a PKC inhibitor peptide [28] , suggesting that PKC did not contribute to the sensitization. It is therefore possible that RuR inhibits MYPT kinases such as Rho-associated kinase [40] or MP-associated MYPT kinase [41] via an unknown pathway and thereby protects MP from thiophosphorylation. Further experiments will be required to address this issue.
Smooth-muscle MP is composed of three subunits : the δ isoform of the catalytic subunit (37 kDa) of type 1 phosphatase (PP1cδ), MYPT (130 kDa), which targets the phosphatase to myosin, and a 20 kDa subunit of unknown function [42] [43] [44] . Three principal ways of inhibiting this phosphatase activity have been described : phosphorylation of MYPT lowers the V max [14] ; dissociation of PP1cδ from the phosphatase holoenzyme disrupts targeting [4] ; and binding of an inhibitor to PP1cδ attenuates phosphatase activity [45] . RuR might act via the third mechanism because it was found to inhibit the activity of purified MP in the absence of MgATP# − . The major mechanism underlying the Ca# + sensitization by RuR might therefore be the direct inhibition of PP1cδ function ; further direct evidence will be required to support this conclusion. In addition, as has been speculated above, RuR conceivably prevents the phosphorylation of MP by kinases such as Rho-associated kinase.
Both microcystin and RuR induced Ca# + -independent contraction in R2G solution (pCa 8) with EC &! values of 59 nM and 843 µM respectively. These Ca# + -independent contractions might be due to LC #! phosphorylation by a kinase distinct from MLCK [39, 46] . The ratio of the IC &! of RuR for the inhibition of purified MP activity to the EC &! of RuR for the activation of Ca# + -independent contraction was 37, whereas that for microcystin was approx. 300. This difference between IC &! for purified phosphatase and EC &! for the contraction of permeabilized muscle by microcystin has previously been reported [47] and might be common among inhibitors of smooth-muscle MP.
The addition of 300 µM to microcystin-induced Ca# + -independent contraction in R2G solution exhibited a dual effect : the potentiation of contraction induced by low concentrations of microcystin (less than 10 nM) and the inhibition of contraction induced by high concentrations of microcystin (more than 300 nM). The synergistic effects of 30 nM microcystin and 300 µM RuR were consistent with the assumption that both agents inhibit MP. The activity of purified MP was totally blocked by 300 µM RuR, regardless of the further addition of 0n01-1 nM microcystin, suggesting that RuR might not compete directly with microcystin to inhibit MP. The mechanism for the marked decrease in 1 µM microcystin-induced contraction by RuR was not elucidated in this study.
It can be concluded that, in addition to several effects of RuR reported so far, RuR directly binds to and inhibits smoothmuscle MP. It is obvious that the inhibition of MP by RuR can occur in Ca# + -free conditions and without interaction with other factors including Ca# + -binding proteins. Although the phosphorylation of MP is not involved in the RuR-induced inhibition of purified MP, we cannot rule out the possibility that MP kinase could also be down-regulated by RuR in permeabilized smooth muscle. However, the inhibition of MP is likely to be the major mechanism underlying Ca# + sensitization of permeabilized smooth-muscle strips by RuR. The inhibitory effect of RuR on MLCK by preventing Ca# + binding to CaM seemed to be functionally masked because an increase in LC #! phosphorylation was observed.
